Key result
Substrate-based catheter ablation with imaging integration effectively manages VT in patients with SHD.
Population
Patients with structural heart disease (ischemic and nonischemic cardiomyopathy) and ventricular tachycardia
Design
Review
Authors
Loading...
Supports substrate-based VT ablation with mapping/imaging in structural heart disease; hypothesis-generating and leaves randomized confirmation open.
Substrate-based catheter ablation, guided by high-density mapping and imaging integration, is emerging as a potential first-line therapy for ventricular tachycardia in patients with structural heart disease.
Sánchez et al. (2017) conducted a review in Ventricular Tachycardia. Catheter ablation was evaluated. Catheter ablation utilizing a systematic substrate-based mapping approach and imaging integration is an effective therapy for managing ventricular tachycardia in patients with structural heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: